ED0B0CDD31DD20E68725897900586A3C Hearing Summary CLICS/CLICS2023A/commsumm.nsf PUBLICBILL SUMMARY For SB23-041HOUSE COMMITTEE ON HEALTH & INSURANCEDate Mar 21, 2023 Location HCR 0112 SB23-041 - Postponed Indefinitely 10:05:51 AM Representatives Amabile and Soper, co-prime bill sponsors, presented Senate Bill 23-041 concerning the authorization of prescription drugs for off-label use. The bill authorizes prescription drugs approved by the Food and Drug Administration (FDA) for off-label use. 10:10:04 AM The committee asked the co-prime bill sponsors questions on the bill. 10:24:14 AM Mrs. Erin Meschke, representing themself, testified in support of the bill and responded to questions from the committee. 10:27:12 AM Nancy Eason, representing themself, testified 10:32:25 AM Jack Teter, representing Planned Parenthood of the Rocky Mountains, testified in opposition to the bill. Ms. Bethany Pray, representing the Colorado Center on Law and Policy, testified in opposition to the bill. The committee asked the panel questions. 10:53:04 AM The co-prime bill sponsors gave closing comments on the bill. Committee members commented on the bill. 10:57:38 AM Motion Refer Senate Bill 23-041 to the Committee of the Whole. Moved Soper Seconded Weinberg Brown No Garcia Excused Hartsook Yes Lieder No McCormick No Ortiz No Soper Yes Titone No Weinberg Yes deGruy Kennedy No Daugherty No YES: 3 NO: 7 EXC: 1 ABS: 0 FINAL ACTION: FAIL 10:58:05 AM Motion Postpone Senate Bill 23-041 indefinitely using a reversal of the previous roll call. There was no objection to the use of the reverse roll call, therefore, the bill was postponed indefinitely. Moved deGruy Kennedy Seconded Ortiz Brown Yes Garcia Excused Hartsook No Lieder Yes McCormick Yes Ortiz Yes Soper No Titone Yes Weinberg No deGruy Kennedy Yes Daugherty Yes Final YES: 7 NO: 3 EXC: 1 ABS: 0 FINAL ACTION: PASS
